Can NIB shares reach $9 by Christmas?

It has been a good few weeks for shareholders. Can the stock keep going?

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price has risen 8% since 8 November 2023 to reach $7.70. Is it possible the NIB share price could go up another 17% to $9 by Christmas?

The ASX healthcare share mainly offers exposure to private health insurance for Australian residents, but it also offers things like non-Australian private health insurance, travel insurance and has growing exposure to the NDIS.

Christmas is only 20 days away, which is a very short timeframe in investment terms. I believe investors should focus on long-term investing, but it's good to consider the outlook for NIB shares.

Expert view on the NIB share price

NIB recently released its AGM trading update for the first few months of FY24, which showed "overall volume and topline momentum is generally upbeat" in UBS' words.

Since June 2023, the Australian resident health insurance division has seen policy numbers rise by 1.3%, implying growth is "tracking towards the top end of the FY24 guidance range of 3% to 4%." Premium growth of 10.5% is tracking ahead of UBS' estimate.

In the international health insurance division, policy numbers have "maintained strong momentum", with 5.2% growth since June 2023, ahead of UBS' forecasts. UBS said premium growth ahead of policy growth indicates repricing support – the broker thinks there is further margin expansion ahead.

In New Zealand, growth is tracking at the low end, while travel policy numbers and premiums were both down in the double-digits because of the end of the Qantas Airways Limited (ASX: QAN) distribution arrangement in July. The Woolworths Group Ltd (ASX: WOW) contract will start contributing in the second half of FY24.

UBS also pointed to claims indicators suggesting that "claims inflation remains under control". Though the company did not detail claims costs in the first quarter of FY24, there are "potential efficiency gains". The broker also suggested recent Medicare monthly data has "generally been supportive."

Forecasts for the ASX healthcare share

The broker has forecast that NIB could generate earnings per share (EPS) of 48 cents and pay an annual dividend per share of 34 cents. That would put the current NIB share price at 16 times FY24's estimated earnings with a grossed-up dividend yield of 6.3%.

The broker rating on NIB shares is a buy, with a price target of $9.50. A price target is for 12 months, not for Christmas, but it does suggest that NIB shares could rise 24% over the next year if UBS ends up being correct.

Should you invest $1,000 in Newcrest Mining right now?

Before you buy Newcrest Mining shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Newcrest Mining wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A worried woman looks at her phone and laptop, seeking ways to tighten her belt against inflation.
Healthcare Shares

This ASX share potentially 'has no value from here', says broker

This is every investor's worst nightmare.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Healthcare Shares

Should I buy Fisher & Paykel or ResMed shares?

Let's see which of these two names could be best buys.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

This company has entered a trading halt, is it about to announce FDA approval?

This regenerative medicine company is up more than 260% in the last year.

Read more »

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

How are Cochlear shares impacted by Trump's tariffs?

Will the company escape from the tariffs? Let's find out.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Healthcare Shares

3 reasons to buy this surging ASX All Ords healthcare share today

A top expert forecasts more outperformance from this rocketing ASX healthcare stock.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Down 11% in 2025, are CSL shares a good buy right now?

Are CSL shares likely to go up from here?

Read more »

Three healthcare workers look and point at at medical image
Healthcare Shares

Pro Medicus to buyback 10.4 million shares. What does this mean?

Is this a sign to buy?

Read more »

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
Healthcare Shares

Why I think this ASX small-cap stock is a bargain at 40 cents

Here’s why this business has a compelling outlook...

Read more »